Global Plasma Reagin Rapid (RPR) Test Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Plasma Reagin Rapid (RPR) Test Market Research Report 2024
The Rapid Plasma Reagin (RPR) test is a blood test used to screen for syphilis, a sexually transmitted infection (STI) caused by the bacterium Treponema pallidum. The RPR test is a non-treponemal test, meaning it does not directly detect the presence of the syphilis bacterium but instead detects antibodies produced by the body in response to the infection.
According to MRAResearch’s new survey, global Plasma Reagin Rapid (RPR) Test market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Plasma Reagin Rapid (RPR) Test market research.
The global market for the Plasma Reagin Rapid (RPR) test was experiencing steady growth due to the increasing prevalence of sexually transmitted infections (STIs) and the rising awareness about the importance of early detection and treatment. The RPR test is a widely used screening tool for syphilis, one of the most common STIs globally. North America held a significant share in the global RPR test market, driven by a high prevalence of STIs and well-established healthcare infrastructure. The region's focus on preventive healthcare and routine STI testing contributed to market growth. Europe was another prominent market for RPR tests, with increasing awareness about STI testing and government initiatives to control syphilis transmission. The Asia-Pacific region witnessed rapid market growth due to the large population, rising awareness about STIs, and efforts to improve healthcare access in developing countries.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Plasma Reagin Rapid (RPR) Test market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Cardinal Health
Abbott
BD
Roche Holding
Thermo Fisher Scientific
Siemens
SEKISUI Diagnostics
Immunostics
Novacyt
Arlington Scientific
Lorne Laboratories
Meridian Bioscience
Bio-Rad Laboratories
Mediclone Biotech
Newmarket Biomedical
Segment by Type
Monoclonal Antibodies Test
Immunofluorescence Test
Fluorescent Treponemal Antibody Absorption Test
T. Pallidum Hemagglutination Assay
Hospitals
Specialty Clinics
Diagnostics Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Plasma Reagin Rapid (RPR) Test report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Plasma Reagin Rapid (RPR) Test market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Plasma Reagin Rapid (RPR) Test market research.
The global market for the Plasma Reagin Rapid (RPR) test was experiencing steady growth due to the increasing prevalence of sexually transmitted infections (STIs) and the rising awareness about the importance of early detection and treatment. The RPR test is a widely used screening tool for syphilis, one of the most common STIs globally. North America held a significant share in the global RPR test market, driven by a high prevalence of STIs and well-established healthcare infrastructure. The region's focus on preventive healthcare and routine STI testing contributed to market growth. Europe was another prominent market for RPR tests, with increasing awareness about STI testing and government initiatives to control syphilis transmission. The Asia-Pacific region witnessed rapid market growth due to the large population, rising awareness about STIs, and efforts to improve healthcare access in developing countries.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Plasma Reagin Rapid (RPR) Test market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Cardinal Health
Abbott
BD
Roche Holding
Thermo Fisher Scientific
Siemens
SEKISUI Diagnostics
Immunostics
Novacyt
Arlington Scientific
Lorne Laboratories
Meridian Bioscience
Bio-Rad Laboratories
Mediclone Biotech
Newmarket Biomedical
Segment by Type
Monoclonal Antibodies Test
Immunofluorescence Test
Fluorescent Treponemal Antibody Absorption Test
T. Pallidum Hemagglutination Assay
Segment by Application
Hospitals
Specialty Clinics
Diagnostics Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Plasma Reagin Rapid (RPR) Test report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source